Fox Chase Cancer Center and Temple Researchers Highlight Need for Molecular Testing in Diagnosing Two Types of Kidney Cancer - Top-Institutions - MDSpire

Fox Chase Cancer Center and Temple Researchers Highlight Need for Molecular Testing in Diagnosing Two Types of Kidney Cancer

Genetic testing may be the most effective way for researchers to distinguish between a rare form of kidney cancer and another that is more common, potentially preventing misdiagnoses, according to a recent study by researchers at Fox Chase Cancer Center and Temple University Hospital.

  • By

  • October 8, 2025

  • 3 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Fox Chase Cancer Center
    Fox Chase Cancer Center

    Philadelphia, PA

    Key Differentiators

    • Oncologic Pathology
    • Molecular Diagnostics
    • Kidney Cancer Research

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Urologic Oncology
    • Molecular Pathology
    • Cancer Genomics

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Cancer Genomics
    • Molecular Diagnostics
    • Kidney Cancer

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Urologic Pathology
    • Molecular Diagnostics
    • Kidney Cancer Research

  • #5

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Molecular Pathology
    • Kidney Cancer
    • Oncologic Diagnostics

Original Source(s)

Fox Chase Cancer Center and Temple Researchers Highlight Need for Molecular Testing in Diagnosing Two Types of Kidney Cancer

  • by

  • October 8, 2025

Related Content

Kidney Cancer Conference Highlights from ASCO GU 2025

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the kidney cancer clinical updates, focused on clear cell renal cell carcinoma (ccRCC), you need to know from GU ASCO 2025.

  • March 3, 2025

  • 1 min
Dana-Farber’s Dr. Toni Choueiri Elected to the Association of American Physicians

Dana-Farber Cancer Institute’s Dr. Toni Choueiri, Director of the Lank Center for Genitourinary Oncology, was recently elected to one of the nation’s most prestigious medical organizations, The Association of American Physicians (AAP).

  • by

  • April 20, 2026

  • 2 min
Systematic Review of Urinary Biomarkers for the Detection of Renal Cell Carcinoma